Source: Presentation program. Conference titles: Brazil MRS Meeting. Unidade: IFSC
Subjects: NANOPARTÍCULAS, CARCINOMA, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODERO, Camila Fernanda et al. Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy. 2025, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2025. Disponível em: https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdf. Acesso em: 19 nov. 2025.APA
Rodero, C. F., Martins, B. M. B., Zapata, A. M. M., & Zucolotto, V. (2025). Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy. In Presentation program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdfNLM
Rodero CF, Martins BMB, Zapata AMM, Zucolotto V. Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy [Internet]. Presentation program. 2025 ;[citado 2025 nov. 19 ] Available from: https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdfVancouver
Rodero CF, Martins BMB, Zapata AMM, Zucolotto V. Development of PLGA nanoparticles encapsulated with paclitaxel and functionalized with bevacizumab for lung carcinoma therapy [Internet]. Presentation program. 2025 ;[citado 2025 nov. 19 ] Available from: https://www.eventweb.com.br/xxiiisbpmat/specific-files/manuscripts/xxiiisbpmat/1506_1748314645.pdf
